生物活性 靶点 体外研究 体内研究
ChemicalBook  CAS数据库列表  N-ETHYLLIDOCAINE BROMIDE

N-ETHYLLIDOCAINE BROMIDE

N-ETHYLLIDOCAINE BROMIDE,24003-58-5,结构式
N-ETHYLLIDOCAINE BROMIDE
  • CAS号:24003-58-5
  • 英文名:N-ETHYLLIDOCAINE BROMIDE
  • 中文名:N-ETHYLLIDOCAINE BROMIDE
  • CBNumber:CB02463601
  • 分子式:C16H27BrN2O
  • 分子量:343.31
  • MOL File:24003-58-5.mol
N-ETHYLLIDOCAINE BROMIDE化学性质
  • 熔点 :214-215 °C
  • 储存条件 :Desiccate at RT
  • 溶解度 :insoluble in EtOH; ≥10.5 mg/mL in H2O; ≥25.55 mg/mL in DMSO
  • 形态 :crystalline solid
  • 颜色 :White
  • 水溶解性 :Soluble to 100 mM in water

N-ETHYLLIDOCAINE BROMIDE性质、用途与生产工艺

  • 生物活性 QX-314 bromide 是一种膜不渗透的钠离子通道永久性电荷阻滞剂。
  • 靶点

    sodium channel

  • 体外研究

    QX-314 bromide exerts biphasic effects on transient receptor potential vanilloid subtype 1 channels (TRPV1) in vitro .
    QX-314 bromide (1–60 mM) directly activates TRPV1 in a concentration-dependent manner.
    QX-314 bromide (≥ 30 mM) produces oocyte membrane blackening and cell death .
    QX-314 bromide inhibits calcium currents in hippocampal CA1 pyramidal neurons intracellular, and the low-threshold (T-type) Ca 2+ currents are on average < 10% of control amplitude .
    QX-314 bromide shifts the current-voltage relationships (I-Vs) in the positive voltage direction due to the presence of intracellular Br- .

  • 体内研究

    QX-314 bromide (1.6 mg/kg; i.c.) abolishes responses to noxious mechanical and thermal stimuli without motor or tactile deficits when co-treatment with capsaicin.

    Animal Model: Male Sprague-Dawley rats (250-290 g)
    Dosage: 1.6 mg/kg
    Administration: Intracutaneous injection
    Result: Abolished responses to noxious mechanical and thermal stimuli without motor or tactile deficits when co-treatment with capsaicin.
N-ETHYLLIDOCAINE BROMIDE上下游产品信息
上游原料
下游产品
N-ETHYLLIDOCAINE BROMIDE生产厂家
  • 公司名称:CLEARSYNTH LABS LTD.
  • 联系电话:--
  • 电子邮件:sales@clearsynth.com
  • 国家:印度
  • 产品数:6257
  • 优势度:58